(Q43008142)

12 November 2017

Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma (English)

1 reference

12 November 2017

Xia Li

1

1 reference

12 November 2017

Li Wang

2

1 reference

12 November 2017

Jian-Wen Gu

3

1 reference

12 November 2017

Bing Li

4

1 reference

12 November 2017

Wei-Ping Liu

5

1 reference

12 November 2017

Yan-Gang Wang

6

1 reference

12 November 2017

Xiang Zhang

7

1 reference

12 November 2017

Hai-Ning Zhen

8

1 reference

12 November 2017

Zhou Fei

9

1 reference

12 November 2017

23 June 2010

1 reference

12 November 2017

1 reference

12 November 2017

31

1 reference

12 November 2017

5

1 reference

12 November 2017

477-488

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-010-0060-6

12 November 2017

0 references

cites work

cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13277-010-0060-6

A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13277-010-0060-6

Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma

21 January 2018

1 reference

12 December 2020

Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior

1 reference

12 December 2020

Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder

1 reference

12 December 2020

Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.

1 reference

12 December 2020

Expression of EphA2 in human astrocytic tumors: correlation with pathologic grade, proliferation and apoptosis.

1 reference

12 December 2020

Up-regulation of ephrin-A1 during melanoma progression

1 reference

12 December 2020

EphA2 as a glioma-associated antigen: a novel target for glioma vaccines

1 reference

12 December 2020

Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.

1 reference

12 December 2020

The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting

1 reference

12 December 2020

Overexpression of the EphA2 tyrosine kinase in prostate cancer.

1 reference

12 December 2020

EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

1 reference

12 December 2020

EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).

1 reference

12 December 2020

ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers

1 reference

12 December 2020

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

1 reference

12 December 2020

The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas

1 reference

12 December 2020

Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma

1 reference

12 December 2020

Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

1 reference

12 December 2020

Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

1 reference

12 December 2020

Control of adhesion-dependent cell survival by focal adhesion kinase

1 reference

12 December 2020

A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma.

1 reference

12 December 2020

EPHA2/EFNA1 expression in human gastric cancer.

1 reference

12 December 2020

Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer

1 reference

12 December 2020

E-cadherin regulates the function of the EphA2 receptor tyrosine kinase

1 reference

12 December 2020

Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.

1 reference

12 December 2020

RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells.

1 reference

12 December 2020

EphA2 as a target for ovarian cancer therapy

1 reference

12 December 2020

Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.

1 reference

12 December 2020

Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness

1 reference

12 December 2020

10.1007/S13277-010-0060-6

Identifiers

DOI

1 reference

Dimensions Publication ID

12 November 2017

0 references

1 reference